Tag Archives: TAVI

Being there first: Personalized medicine and the investor

I don’t directly invest in med-tech, but attending Transcatheter Cardiovascular Therapeutics for five years makes me wonder how an investor separates winners and losers. I know TCT 2011 has both, but which are which? Asking about the patient population is…

FacebookTwitterGoogle+Share

The Good, the Bad and the Ugly: Third-party coverage requests

As a member of the trade press, I get a kick out of how routinely some people in the mainstream media and the population at large routinely assume that device makers are driven by greed and that doctors are morally…

FacebookTwitterGoogle+Share

Top Five Things to Watch for in 2011

In the world of diagnostic and therapeutic devices, 2011 has already been a busy year, but a third of the year remains. There are still numerous developments that will trigger cheer and jeers, depending on where you sit. This is…

FacebookTwitterGoogle+Share

FDA to small firms: Thanks but no thanks

There’s nothing like having siblings who are several years older and in their teens. You admire them for being so mature and so big. When you wanted to hang out with them, though, maybe they told you to buzz off….

FacebookTwitterGoogle+Share

TAVR looked upon as next med-tech blockbuster, but is it ready for primetime?

It’s easy to understand the excitement about the PARTNER trial, sponsored by Edwards Lifesciences (Irvine, California), the company that makes the much talked about transcatheter aortic valve replacement (TAVR) device, called the Sapien. After all, given the choice between open…

FacebookTwitterGoogle+Share

Marketo